US Stock MarketDetailed Quotes

PDS Biotechnology (PDSB)

Watchlist
  • 0.9005
  • -0.0276-2.97%
Close Apr 24 16:00 ET
  • 0.9006
  • +0.0001+0.01%
Post 19:48 ET
50.26MMarket Cap-1.22P/E (TTM)

PDS Biotechnology (PDSB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.78%-27.75M
55.04%-3.7M
26.05%-5.92M
-2.75%-9.1M
9.12%-9.03M
-4.14%-35.03M
2.63%-8.23M
-11.48%-8M
-83.99%-8.86M
24.65%-9.94M
Net income from continuing operations
8.28%-34.5M
4.90%-7.56M
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
Operating gains losses
--1.11M
--354.17K
----
----
----
----
----
----
----
----
Depreciation and amortization
3.43%21.84K
0.02%5.46K
-0.02%5.46K
0.00%5.46K
15.29%5.46K
21.62%21.11K
15.27%5.46K
15.36%5.46K
15.27%5.46K
50.08%4.74K
Other non cash items
29.29%1.89M
88.36%579.08K
-194.51%-297.51K
100.50%1.12M
73.54%485.75K
-21.94%1.46M
-54.84%307.44K
51.17%314.8K
-29.19%560.44K
44.87%279.91K
Change In working capital
93.34%-382.97K
178.75%1.76M
120.56%1.39M
56.98%-1.24M
-83.16%-2.29M
-2,786.31%-5.75M
-658.83%-2.24M
-54.68%628.44K
-175.72%-2.89M
78.48%-1.25M
-Change in prepaid assets
80.06%-173.56K
578.26%4.71M
68.35%80.29K
-316.53%-1.57M
-866.21%-3.4M
-625.31%-870.29K
-1,165.02%-984.79K
-65.67%47.69K
-883.69%-376.4K
489.61%443.21K
-Change in payables and accrued expense
95.71%-209.41K
-134.90%-2.95M
124.85%1.31M
112.87%323.73K
165.44%1.11M
-3,790.24%-4.88M
-506.97%-1.25M
-55.60%580.75K
-165.15%-2.52M
69.79%-1.69M
-Change in other current liabilities
--0
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
20.78%-27.75M
55.04%-3.7M
26.05%-5.92M
-2.75%-9.1M
9.12%-9.03M
-4.14%-35.03M
2.63%-8.23M
-11.48%-8M
-83.99%-8.86M
24.65%-9.94M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-29K
0
-1
Net PPE purchase and sale
--0
--0
--0
----
----
---29K
--0
---1
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
----
----
---29K
--0
---1
----
----
Financing cash flow
Cash flow from continuing financing activities
-36.72%12.77M
2,340.07%4.22M
1,301.05%241.21K
7,324.31%995.94K
-63.42%7.32M
23.28%20.19M
-98.40%172.78K
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
Net issuance payments of debt
-137.77%-7.56M
6.25%-2.94M
-7,099.20%-1.02M
-3,270.96%-464.72K
-23,200.64%-3.14M
-5,263.90%-3.18M
-23,735.92%-3.14M
-9.54%-14.11K
-9.53%-13.79K
34.80%-13.48K
Net common stock issuance
-38.11%13.98M
25.19%3.97M
1,970.60%1.26M
--1.46M
-62.55%7.3M
40.11%22.6M
-69.77%3.17M
-108.24%-67.18K
--0
324.85%19.49M
Proceeds from stock option exercised by employees
720.83%6.35M
2,109.81%3.19M
--0
--3.16M
-99.99%71
150.56%774.09K
-51.85%144.5K
--98.5K
--0
--531.09K
Net other financing activities
----
----
----
----
--3.16M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-36.72%12.77M
2,340.07%4.22M
1,301.05%241.21K
7,324.31%995.94K
-63.42%7.32M
23.28%20.19M
-98.40%172.78K
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
Net cash flow
Beginning cash position
-26.29%41.69M
-47.34%26.2M
-44.79%31.87M
-40.00%39.98M
-26.29%41.69M
-23.38%56.56M
-8.29%49.75M
-4.77%57.73M
2.20%66.63M
-23.38%56.56M
Current changes in cash
-0.72%-14.98M
106.37%513.32K
28.91%-5.67M
8.94%-8.11M
-116.98%-1.71M
13.84%-14.87M
-449.12%-8.06M
-25.24%-7.98M
-94.58%-8.9M
216.86%10.07M
End cash Position
-35.93%26.71M
-35.93%26.71M
-47.34%26.2M
-44.79%31.87M
-40.00%39.98M
-26.29%41.69M
-26.29%41.69M
-8.29%49.75M
-4.77%57.73M
2.20%66.63M
Free cash flow
20.84%-27.75M
55.04%-3.7M
26.05%-5.92M
-2.41%-9.1M
9.12%-9.03M
-4.23%-35.06M
2.63%-8.23M
-11.48%-8M
-84.59%-8.89M
24.65%-9.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.78%-27.75M55.04%-3.7M26.05%-5.92M-2.75%-9.1M9.12%-9.03M-4.14%-35.03M2.63%-8.23M-11.48%-8M-83.99%-8.86M24.65%-9.94M
Net income from continuing operations 8.28%-34.5M4.90%-7.56M16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M
Operating gains losses --1.11M--354.17K--------------------------------
Depreciation and amortization 3.43%21.84K0.02%5.46K-0.02%5.46K0.00%5.46K15.29%5.46K21.62%21.11K15.27%5.46K15.36%5.46K15.27%5.46K50.08%4.74K
Other non cash items 29.29%1.89M88.36%579.08K-194.51%-297.51K100.50%1.12M73.54%485.75K-21.94%1.46M-54.84%307.44K51.17%314.8K-29.19%560.44K44.87%279.91K
Change In working capital 93.34%-382.97K178.75%1.76M120.56%1.39M56.98%-1.24M-83.16%-2.29M-2,786.31%-5.75M-658.83%-2.24M-54.68%628.44K-175.72%-2.89M78.48%-1.25M
-Change in prepaid assets 80.06%-173.56K578.26%4.71M68.35%80.29K-316.53%-1.57M-866.21%-3.4M-625.31%-870.29K-1,165.02%-984.79K-65.67%47.69K-883.69%-376.4K489.61%443.21K
-Change in payables and accrued expense 95.71%-209.41K-134.90%-2.95M124.85%1.31M112.87%323.73K165.44%1.11M-3,790.24%-4.88M-506.97%-1.25M-55.60%580.75K-165.15%-2.52M69.79%-1.69M
-Change in other current liabilities --0------------------0--0--0--0--0
Cash from discontinued investing activities
Operating cash flow 20.78%-27.75M55.04%-3.7M26.05%-5.92M-2.75%-9.1M9.12%-9.03M-4.14%-35.03M2.63%-8.23M-11.48%-8M-83.99%-8.86M24.65%-9.94M
Investing cash flow
Cash flow from continuing investing activities 000-29K0-1
Net PPE purchase and sale --0--0--0-----------29K--0---1--------
Cash from discontinued investing activities
Investing cash flow --0--0--0-----------29K--0---1--------
Financing cash flow
Cash flow from continuing financing activities -36.72%12.77M2,340.07%4.22M1,301.05%241.21K7,324.31%995.94K-63.42%7.32M23.28%20.19M-98.40%172.78K-97.85%17.22K-105.74%-13.79K338.11%20.01M
Net issuance payments of debt -137.77%-7.56M6.25%-2.94M-7,099.20%-1.02M-3,270.96%-464.72K-23,200.64%-3.14M-5,263.90%-3.18M-23,735.92%-3.14M-9.54%-14.11K-9.53%-13.79K34.80%-13.48K
Net common stock issuance -38.11%13.98M25.19%3.97M1,970.60%1.26M--1.46M-62.55%7.3M40.11%22.6M-69.77%3.17M-108.24%-67.18K--0324.85%19.49M
Proceeds from stock option exercised by employees 720.83%6.35M2,109.81%3.19M--0--3.16M-99.99%71150.56%774.09K-51.85%144.5K--98.5K--0--531.09K
Net other financing activities ------------------3.16M--------------------
Cash from discontinued financing activities
Financing cash flow -36.72%12.77M2,340.07%4.22M1,301.05%241.21K7,324.31%995.94K-63.42%7.32M23.28%20.19M-98.40%172.78K-97.85%17.22K-105.74%-13.79K338.11%20.01M
Net cash flow
Beginning cash position -26.29%41.69M-47.34%26.2M-44.79%31.87M-40.00%39.98M-26.29%41.69M-23.38%56.56M-8.29%49.75M-4.77%57.73M2.20%66.63M-23.38%56.56M
Current changes in cash -0.72%-14.98M106.37%513.32K28.91%-5.67M8.94%-8.11M-116.98%-1.71M13.84%-14.87M-449.12%-8.06M-25.24%-7.98M-94.58%-8.9M216.86%10.07M
End cash Position -35.93%26.71M-35.93%26.71M-47.34%26.2M-44.79%31.87M-40.00%39.98M-26.29%41.69M-26.29%41.69M-8.29%49.75M-4.77%57.73M2.20%66.63M
Free cash flow 20.84%-27.75M55.04%-3.7M26.05%-5.92M-2.41%-9.1M9.12%-9.03M-4.23%-35.06M2.63%-8.23M-11.48%-8M-84.59%-8.89M24.65%-9.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More